Researchers will assess how well specific chemotherapy drugs work as an adjunct therapy for dogs recovering from bone cancer surgery.

Researchers will assess the value of a genetic prognostic tool to assist with treatment decisions for dogs with diffuse large B-cell lymphoma.

Researchers will investigate the use of a commercially available, collar-mounted activity monitor to detect seizures in dogs with epilepsy.

Researchers will investigate the role of a small protein released in response to inflammation as a potential new therapy target to control itch and inflammation in dogs with chronic, relapsing allergic skin disease.

Researchers will measure changes in circulating cancerous T-cells in dogs with lymphoma to gauge chemotherapy drug resistance and tailor treatments for individual patients with this aggressive and common cancer.

Researchers will investigate the prevalence and disease impact of canine circovirus in dogs.

Researchers will explore drug treatments that target a genetic mutation associated with bladder cancer in dogs.

Researchers will assess the safety and benefits of intensive, postoperative rehabilitation in dogs recovering from spinal cord injuries.

Researchers will investigate a novel therapeutic target for mammary gland cancer in dogs.

Researchers will create an optical map of the canine genome, an important tool to identify gaps and missing structural components in the current canine genome assembly.